AMAG Pharmaceuticals to Present at the Needham Healthcare Conference
March 28 2017 - 8:00AM
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that
management will present at the 16th Annual Needham Healthcare
Conference on Tuesday, April 4, 2017 at 4:20 p.m. ET.
A live audio webcast will be accessible through the
Investors section of the company’s website
at www.amagpharma.com, and will be archived for 30
days.
About AMAGAMAG is
a biopharmaceutical company focused on developing and delivering
important therapeutics, conducting clinical research in areas of
unmet need and creating education and support programs for the
patients and families we serve. Our currently marketed products
support the health of patients in the areas of women’s health,
anemia management and cancer supportive care. Through CBR®, we also
help families to preserve newborn stem cells, which are used today
in transplant medicine for certain cancers and blood, immune and
metabolic disorders, and have the potential to play a valuable role
in the ongoing development of regenerative medicine. For additional
company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark
of AMAG Pharmaceuticals, Inc. and CBR® is a registered
trademark of CBR Systems, Inc.
AMAG Pharmaceuticals Contact:
Christi Waarich
Associate Director, Investor Relations
617-498-7638
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Mar 2024 to Apr 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Apr 2023 to Apr 2024